Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

ClinicalTrials.gov ID: NCT05098132

Public ClinicalTrials.gov record NCT05098132. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2 Study to Evaluate STK-012 as a Single Agent and in Combination Therapy in Subjects With Front-line Advanced NSCLC and Other Selected Indications

Study identification

NCT ID
NCT05098132
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Synthekine
Industry
Enrollment
364 participants

Conditions and interventions

Interventions

  • STK-012 Drug
  • carboplatin Drug
  • pembrolizumab Drug
  • pemetrexed Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 24, 2022
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028
Last update posted
Mar 17, 2026

2022 – 2029

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
University of Arizona Cancer Center Tucson Arizona 85721 Recruiting
Beverly Hills Cancer Center Beverly Hills California 90211 Recruiting
Providence Medical Foundation Fullerton California 92835 Recruiting
UC San Diego Moores Cancer Center La Jolla California 92093-0698 Active, not recruiting
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 Recruiting
UCLA Hematology/Oncology - Santa Monica Santa Monica California 90404 Recruiting
Yale New Haven Hospital, Yale Cancer Center New Haven Connecticut 06510 Recruiting
Georgetown University Washington D.C. District of Columbia 20057 Recruiting
Winship Cancer Institute, Emory University Atlanta Georgia 30322 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 Recruiting
Dana-Farber Cancer Institute Boston Massachusetts 02215 Recruiting
HealthPartners Cancer Center at Regions Hospital Saint Paul Minnesota 55101 Recruiting
Northwell Health Lake Success New York 11042 Recruiting
NYU Langone Health New York New York 10016 Recruiting
Columbia University Irving Medical Center New York New York 10032 Active, not recruiting
Memorial Sloan-Kettering Cancer Center New York New York 10065 Recruiting
Duke Cancer Center Durham North Carolina 27710 Recruiting
The James Cancer Hospital and Solove Research Institute Columbus Ohio 43210 Recruiting
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 Active, not recruiting
Baptist Memorial Hospital Cancer Center Memphis Tennessee 38120 Recruiting
Sarah Cannon Research Institute - Nashville Nashville Tennessee 37203 Active, not recruiting
Renovatio Clinical El Paso Texas 79915 Withdrawn
Oncology Consultants Houston Texas 77303 Recruiting
Renovatio Clinical The Woodlands Texas 77380 Withdrawn
NEXT Virginia Fairfax Virginia 22031 Recruiting
Northwest Medical Specialties Tacoma Washington 98405 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05098132, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 17, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05098132 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →